1. NFM-09. PRELIMINARY REPORT OF A MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY. Issue 2 (22nd June 2018) Authors: Tonsgard, James; Ullrich, Nicole; Blakeley, Jaishri; Rosser, Tena; Packer, Roger; Korf, Bruce; Fisher, Michael; Cutter, Gary; Plotkin, Scott; Karajannis, Matthias; Allen, Jeffrey; Wade Clapp, D; Thomas, Coretta; Campian, Jian Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study. Issue 10 (1st April 2020) Authors: Ullrich, Nicole J; Prabhu, Sanjay P; Reddy, Alyssa T; Fisher, Michael J; Packer, Roger; Goldman, Stewart; Robison, Nathan J; Gutmann, David H; Viskochil, David H; Allen, Jeffrey C; Korf, Bruce; Cantor, Alan; Cutter, Gary; Thomas, Coretta; Perentesis, John P; Mizuno, Tomoyuki; Vinks, Alexander A; ... Journal: Neuro-oncology Issue: Volume 22:Issue 10(2020) Page Start: 1527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. NFB-17. MEK INHIBITOR BINIMETINIB SHOWS CLINICAL ACTIVITY IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1- ASSOCIATED PLEXIFORM NEUROFIBROMAS: A REPORT FROM PNOC AND THE NF CLINICAL TRIALS CONSORTIUM. (4th December 2020) Authors: Mueller, Sabine; Reddy, Alyssa T; Dombi, Eva; Allen, Jeffrey; Packer, Roger; Clapp, Wade; Goldman, Stewart; Schorry, Elizabeth; Tonsgard, James; Blakeley, Jaishri; Ullrich, Nicole J; Gross, Andrea; Walsh, Karin; Thomas, Coretta; Edwards, Lloyd; Prados, Michael; Korf, Bruce; Fisher, Michael J Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 3 Page Start: iii420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CTNI-10. MAINTENANCE CHEMOTHERAPY USING BEVACIZUMAB FOR NEUROFIBROMATOSIS 2 PATIENTS WITH HEARING LOSS AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY (NF104). (9th November 2020) Authors: Plotkin, Scott; Tonsgard, James; Ullrich, Nicole; Allen, Jeffrey; Blakeley, Jaishri; Dhall, Girish; Campian, Jian; Clapp, Wade; Fisher, Michael; Cutter, Gary; Korf, Bruce; Packer, Roger; Thomas, Coretta; Edwards, Lloyd; Karajannis, Matthias Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗